Enanta Pharma (ENTA) Misses Q2 EPS by 13c, updates expense guidance

Go back to Enanta Pharma (ENTA) Misses Q2 EPS by 13c, updates expense guidance
ENANTA PHARM (NASDAQ: ENTA) Delayed: 13.50 --0 (-0%)
Previous Close $13.50    52 Week High $34.49 
Open $13.50    52 Week Low $20.39 
Day High $13.50    P/E N/A 
Day Low $13.50    EPS $-3.18 
Volume